奎斯特诊断 DGX
$255.63 +$0.89 (+0.35%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $255.63 0.00%
开盘$251.64
昨收$254.74
当日区间$250.00 – $258.13
成交量945.2K
市值$28.12B
市盈率（TTM）25.5
股息率1.32%
DGX 相关新闻
匹配 Quest Diagnostics 或代码 DGX 的头条新闻，按最新排序。
- UBS Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $245 正面
- Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $250
- Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $260
- Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $260 正面
- Quest Diagnostics(DGX.US) Officer Sells US$5.51 Million in Common Stock
- Morgan Stanley Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260
- Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260
- Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $250
- Argus Research Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $260 正面
- J.P. Morgan Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $250 正面
- A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $265
- A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $260
- Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $230
- BofA Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $245 正面
- Baird Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $236 正面
暂无评论——快来第一个聊聊 DGX。
登录后参与讨论。